Parasagittal meningioma and chronic subdural hematoma, unusual association
Keywords:
parasagittal meningioma, chronic subdural hematomaAbstract
In many cases, patients with brain tumors have a variety of nonspecific psychiatric symptoms. Some of them can be the first or the only manifestation of the tumor, without presenting any neurological signs or symptoms. The diagnosis must be based on the complete anamnesis and on the neurological examination. The neuroimaging will confirm the clinical diagnosis. The unusual association of a chronic subdural hematoma and a parasagittal meningioma was described in a case presented in the current work. It dealt with a patient, aged 68 years with antecedents of schizophrenia. He assisted the consultation with left hemiparesis. A skull computed tomography showed a chronic subdural hematoma and a right parasagittal meningioma. He underwent a two-steps surgery. His post-surgery evolution ran without complications.Downloads
References
2. Balser D, Farooq S, Mehmood T, et al. Actual and projected incidence rates for chronic subdural hematomas in United States Veterans Administration and civilian populations. J Neurosurg. 2015 Nov; 123(5): 1209-15. Citado en PubMed; PMID: 25794342.
3. Miranda-Zambrano AD. Influencia del tratamiento corticoideo en la recurrencia y el tiempo de resolución de los hematomas subdurales crónicos [tesis en internet]. Salamanca: Universidad de Salamanca; 2015 [citado 12/10/2019]. Disponible en: https://gredos.usal.es/handle/10366/128230.
4. Puente T, Marlin R, Reyes G, et al. Recuperación de pacientes en postoperatorio de drenaje de hematoma subdural crónico asociado al uso de ácido tranexámico. Rev Chil Neurocirugía [Internet]. 2016 [citado 12/10/2019]; 42: 45-51. Disponible en: https://www.neurocirugiachile.org/pdfrevista/v42_n1_2016/puente_p45_v42n1_2016.pdf.
5. Huang J, Gao C, Dong J, et al. Drug treatment of chronic subdural hematoma. Expert Opin Pharmacother. 2020 Mar; 21(4): 435-44. Citado en PubMed; PMID: 31957506.
6. Chacín González JP, Reyes Graterol EO, García Oduber SM. Factores relacionados a complicaciones asociadas al uso de ácido tranexámico en pacientes con cirugía de drenaje de hematoma subdural. Rev Chil Neurocirugía [Internet]. 2018 [citado 12/10/2019]; 44: 25-31. Disponible en: https://www.neurocirugiachile.org/pdfrevista/v44_n1_2018/chacin_p25_v44n1_2018.pdf.
7. Yadav YR, Ratre S, Parihar V, et al. Endoscopic Management of Chronic Subdural Hematoma. J Neurol Surg A Cent Eur Neurosurg. 2020 Jul; 81(4): 330-41. Citado en PubMed; PMID: 32176925.
8. Rauhala M, Helén P, Huhtala H, et al. Chronic subdural hematoma-incidence, complications, and financial impact. Acta Neurochir. 2020 Sep; 162(9): 2033-43. Citado en PubMed; PMID: 32524244.
9. Pradilla G, Solero CL, Dimeco F. Parasagittal meningiomas. En: De Monte F, Mc Dermott MW, Al-mefty O (eds.): Al-mefty’s meningiomas. 2da ed. New York: Thieme; 2016. p. 145.
10. Cabello-Rangel H, Díaz-Castro L. Síndrome del lóbulo frontal con síntomas psicóticos secundario a meningioma gigante en varón de 38 años de edad. Actas Esp Psiquiatr [Internet]. 2016 [citado 12/10/2019]; 44(6): 244-52. Disponible en: https://medes.com/publication/117381.
11. Winn R. Youmans. Brain Tumor Outcome Studies. Cap. 126; New York: Elsevier; 2016. p. 930.
12. Alruwaili AA, De Jesus O. Meningioma. En: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan. Citado en PubMed; PMID: 32809373.
13. Simpson D. The recurrence of the intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry. 1957 Feb; 20(1): 22-39. Citado en PubMed; PMID: 13406590.
14. Kinjo T, Al-Mefty O, Kanaan I. Grade zero removal of supratentorial convexity meningiomas. Neurosurgery. 1993; 33(3): 394-9. Citado en PubMed; PMID: 8413869.
15. Toledo E, Shalit M, Segal R. Spinal Subdural Hematoma Associated with Anticoagulant Therapy in a Patient with Spinal Meningioma. Neurosurgery. 1981 May; 8(5): 600-3. Citado en PubMed; PMID: 7266805.
Published
How to Cite
Issue
Section
License
All content published in this journal is Open Access, distributed under the terms of the CC BY-NC 4.0 License.
It allows:
- Copy and redistribute published material in any medium or format.
- Adapt the content.
This will be done under the following terms:
- Attribute the authors' credits and indicate whether changes were made, in which case it must be in a reasonable way.
- Non-commercial use.
- Recognize the journal where it is published.
The copyrights of each article are maintained, without restrictions.